Australia markets closed

Boston Scientific Corporation (BSX)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
77.00+0.69 (+0.90%)
At close: 04:00PM EDT
76.91 -0.09 (-0.12%)
Pre-market: 06:43AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 113.20B
Enterprise value 121.88B
Trailing P/E 64.71
Forward P/E 33.00
PEG ratio (5-yr expected) 1.90
Price/sales (ttm)7.71
Price/book (mrq)5.68
Enterprise value/revenue 8.29
Enterprise value/EBITDA 33.55

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 342.67%
S&P500 52-week change 325.87%
52-week high 377.64
52-week low 348.35
50-day moving average 373.42
200-day moving average 362.24

Share statistics

Avg vol (3-month) 35.91M
Avg vol (10-day) 35.15M
Shares outstanding 51.47B
Implied shares outstanding 61.47B
Float 81.47B
% held by insiders 10.19%
% held by institutions 192.80%
Shares short (15 May 2024) 412.33M
Short ratio (15 May 2024) 41.76
Short % of float (15 May 2024) 40.84%
Short % of shares outstanding (15 May 2024) 40.84%
Shares short (prior month 15 Apr 2024) 413.16M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 306 Nov 2003

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 12.05%
Operating margin (ttm)17.97%

Management effectiveness

Return on assets (ttm)4.54%
Return on equity (ttm)9.25%

Income statement

Revenue (ttm)14.71B
Revenue per share (ttm)10.06
Quarterly revenue growth (yoy)13.80%
Gross profit (ttm)N/A
EBITDA 3.74B
Net income avi to common (ttm)1.76B
Diluted EPS (ttm)1.19
Quarterly earnings growth (yoy)57.30%

Balance sheet

Total cash (mrq)2.33B
Total cash per share (mrq)1.58
Total debt (mrq)11B
Total debt/equity (mrq)54.55%
Current ratio (mrq)1.66
Book value per share (mrq)13.56

Cash flow statement

Operating cash flow (ttm)2.48B
Levered free cash flow (ttm)1.65B